Abstract
Purpose: Treatment of hormone receptor-positive early breast cancer (HR+EBC) in patients who are unfit for or decline radical treatment requires careful consideration of tumour parameters against functional status, co-morbidities and quality of life. In this retrospective study we reviewed the outcomes of patients treated with primary endocrine therapy (PET) in a single UK centre.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
